法律人 LawPlayer logo

資料由法律人 LawPlayer整理提供·EU law / curated by LawPlayer from EUR-Lex

Regulation

Commission Implementing Regulation (EU) 2020/1511 of 16 October 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, picloram, prosulfocarb, sulphur, triflusulfuron and tritosulfuron (Text with EEA relevance)

CELEX
Implementing Regulation (EU) 2020/1511
Date of document
Articles
3
Source
EUR-Lex
Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2021’;

(2)

in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2021’;

(3)

in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2021’;

(4)

in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2021’;

(5)

in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2021’;

(6)

in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2021’;

(7)

in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2021’;

(8)

in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2021’;

(9)

in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2021’;

(10)

in the sixth column, expiration of approval, of row 160, Prosulfocarb, the date is replaced by ‘31 October 2021’;

(11)

in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘31 October 2021’;

(12)

in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘31 October 2021’;

(13)

in the sixth column, expiration of approval, of row 169, Amidosulfuron, the date is replaced by ‘31 December 2021’;

(14)

in the sixth column, expiration of approval, of row 170, Nicosulfuron, the date is replaced by ‘31 December 2021’;

(15)

in the sixth column, expiration of approval, of row 171, Clofentezine, the date is replaced by ‘31 December 2021’;

(16)

in the sixth column, expiration of approval, of row 172, Dicamba, the date is replaced by ‘31 December 2021’;

(17)

in the sixth column, expiration of approval, of row 173, Difenoconazole, the date is replaced by ‘31 December 2021’;

(18)

in the sixth column, expiration of approval, of row 176, Lenacil, the date is replaced by ‘31 December 2021’;

(19)

in the sixth column, expiration of approval, of row 178, Picloram, the date is replaced by ‘31 December 2021’;

(20)

in the sixth column, expiration of approval, of row 180, Bifenox, the date is replaced by ‘31 December 2021’;

(21)

in the sixth column, expiration of approval, of row 181, Diflufenican, the date is replaced by ‘31 December 2021’;

(22)

in the sixth column, expiration of approval, of row 182, Fenoxaprop-P, the date is replaced by ‘31 December 2021’;

(23)

in the sixth column, expiration of approval, of row 183, Fenpropidin, the date is replaced by ‘31 December 2021’;

(24)

in the sixth column, expiration of approval, of row 186, Tritosulfuron, the date is replaced by ‘30 November 2021’;

(25)

in the sixth column, expiration of approval, of row 289, Triflusulfuron, the date is replaced by ‘31 December 2021’;

(26)

in the sixth column, expiration of approval, of row 292, Sulphur, the date is replaced by ‘31 December 2021’;

(27)

in the sixth column, expiration of approval, of row 294, Paraffin oils, the date is replaced by ‘31 December 2021’.

3 articles

Cite this act

Commission Implementing Regulation (EU) 2020/1511 of 16 October 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, picloram, prosulfocarb, sulphur, triflusulfuron and tritosulfuron (Text with EEA relevance) (EUR-Lex). Retrieved via LawPlayer, https://lawplayer.com/eu/act/32020R1511

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

EU-EurLex-Reuse-2011-833

本頁資料來源:EUR-Lex·整理提供:法律人 LawPlayer· lawplayer.com